Revelation Biosciences (REVB) has released an update to notify the public and investors about an entry into a material definitive agreement.
Revelation Biosciences, Inc. has successfully completed a registered public offering, raising approximately $6.2 million by selling shares and warrants, which include pre-funded warrants with a nominal exercise price to certain investors. These transactions were managed by Roth Capital Partners, LLC, and involved specific agreements that contained standard representations and covenants, along with an agreement with the company’s transfer agent regarding the terms of the warrants. Additionally, the company’s executives and directors are restricted from selling their securities for 90 days post-offering. The offering was made under a previously filed and effective SEC registration statement.
For further insights into REVB stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
